# BNP Paribas — Income Investment

- Data cutoff: **2026-07-15, 14:12 CEST**
- Security: **BNP Paribas SA**, Euronext Paris, ISIN `FR0000131104`, EUR
- Portfolio snapshot: `data/Portfolio-degiro-20260715.csv`; CTO DEGIRO; tax residence France
- Evidence quality: **A-** — current primary financial, prudential and dividend documents are available; 2Q26 results are not due until 2026-07-23, and DEGIRO withholding mechanics were not independently confirmed
- Purpose: learning and research, not investment advice

Classification convention: **Verified fact** comes from a cited source or the supplied portfolio; **Estimate** is a calculation from those facts; **Assumption** defines a scenario; **Analytical judgment** is the research conclusion.

## 1. Executive summary

**Analytical judgment — `HOLD – DO NOT ADD`.** BNP Paribas fits **conviction + durable income** better than opportunistic income: its diversified banking franchise, 50% minimum cash-dividend policy and regulatory-capital headroom support the distribution. It is not a yield trap. The constraint is allocation and price, not present dividend safety.

**Verified fact.** For 2025 BNP reported €10.29 EPS and paid €5.16 per share, a 50% cash payout. At 31 March 2026, CET1 was 12.8% against a 10.42% SREP requirement; 1Q26 net income rose 9.0% to €3.217bn, while cost of risk reached 39 bps, close to management's 2026 ceiling of below 40 bps.

**Estimate.** At the supplied €102.32 close, the trailing gross yield is 5.04%, PE is 9.94× and price/book is 0.98×. The three-share holding produces €15.48 annual gross income on the last declared annual dividend, or €10.62 under a simplified 2026 French PFU scenario of 31.4%. The latter is not a forecast of DEGIRO cash receipts.

**Analytical judgment.** The current price offers a fair dividend-led return but little margin of safety for bank, credit-cycle and litigation tail risk. The latest portfolio review already says no immediate trade; BNP is 3.43% of assets and total financial exposure is 21.38%. Reinforcement should wait for both a price at or below €90 and lower portfolio financial concentration.

## 2. Verdict and category

**Verdict: `HOLD – DO NOT ADD`**

- **Possible role:** existing 2–4% satellite/core-income bank position, not a stand-alone defensive bond substitute.
- **Primary reason:** earnings, capital and the stated payout policy presently cover a growing semiannual dividend.
- **Primary risk:** a credit/legal shock can consume capital and make a regulated bank's payout discretionary.
- **Entry condition:** study below €90, only if CET1 remains at least 12.5%, cost of risk remains at or below roughly 40–45 bps, and portfolio finance exposure falls to about 20% or less.
- **Position-size range to study:** 2–4% of portfolio value; 5% is a monitoring ceiling, not a universal recommendation.
- **Reinforcement condition:** price at or below €90 plus unchanged capital/distribution thesis and no adverse Sudan-litigation development.
- **Reduction/exit criteria:** CET1 below 11.5%, cost of risk above 60 bps for two reporting periods, dividend cut not caused solely by a system-wide temporary regulator ban, or weight above 5% without improved diversification.
- **Monitoring:** CET1, distance to MDA restrictions, cost of risk, impaired loans, 2026 interim dividend, legal provisions and Sudan appeal.
- **Confidence:** medium-high on current safety; medium on five-year growth because banks are cyclical and regulated.

### Qualitative scorecard

| Dimension | Rating | Evidence |
|---|---|---|
| Business quality | Strong | Diversified European commercial banking, CIB, insurance and asset management |
| Cash-flow visibility | Adequate | Recurring spread and fee income, offset by credit and trading cyclicality |
| Dividend coverage | Strong | 2025 cash payout 50%; EPS coverage 1.99× |
| Balance-sheet strength | Strong | 12.8% CET1 vs 10.42% requirement; €18bn CET1 distance to MDA |
| Distribution history | Adequate | Five consecutive annual increases from 2020–2025, but 2019 distribution was suspended under the ECB pandemic recommendation |
| Dividend growth potential | Adequate | 8.89% 2021–2025 CAGR is unlikely to be a permanent run rate |
| Valuation | Adequate | 9.94× 2025 EPS and 0.98× book; current yield below the five-year year-end proxy |
| Cyclicality | Weak | Credit losses, rates, markets and regulation are macro-sensitive |
| Cut risk | Adequate | Low near term absent shock; meaningful in a severe recession or legal/capital event |
| Portfolio fit | Weak | Finance is already 21.38% of the supplied portfolio |

### Blocking gates

| Gate | Result | Reason |
|---|---|---|
| Recurring uncovered distribution | Pass | 2025 dividend was covered 1.99× by EPS |
| Critical debt/refinancing risk | Pass | Capital, liquidity and regulatory funding headroom are adequate |
| Structural business deterioration | Pass | 1Q26 revenue and profit grew; no structural decline established |
| Insufficient fundamental data | Pass | Current primary disclosures available; 2Q26 is pending |
| Material governance/integrity concern | Pass with watch | Sudan litigation is material and unresolved, but current evidence does not establish a payout-blocking loss |

## 3. Possible portfolio role

**Analytical judgment.** BNP can provide EUR-denominated, growing bank income and exposure to a diversified European financial franchise. It is less suitable as a defensive income anchor because bank dividends depend on capital ratios, regulator consent, credit costs and market confidence.

**Analytical judgment.** The holding is conviction income rather than opportunistic yield: there is no short-term catalyst/exit structure, and the 5.04% trailing yield is not unusually high against BNP's own recent year-end yield proxy. The sensible role is a maintained small position, not a yield-driven trade.

## 4. Business and source of distributed cash

**Verified fact.** BNP earns net banking income from Commercial, Personal Banking & Services, Corporate & Institutional Banking, and Investment & Protection Services. 1Q26 net banking income was €14.056bn: CPBS €6.852bn, CIB €5.243bn and IPS €1.980bn before corporate-centre effects.

**Analytical judgment.** For a bank, free cash flow and net debt are misleading distribution measures. The relevant chain is recurring net income → retained earnings/CET1 generation → regulatory headroom → board/AGM distribution. Deposits and wholesale debt are operating funding, not industrial-company leverage.

**Verified fact.** BNP's 2026 distribution policy is 60% of earnings, with at least 50% in cash dividends and 10% in buybacks. Buybacks compete with retained capital but are the more flexible component; the dividend is the income component.

## 5. Dividend history and calendar

| Earnings year | Gross dividend/share | Change | Status |
|---:|---:|---:|---|
| 2020 | €2.66 | — | Verified fact |
| 2021 | €3.67 | +38.0% | Verified fact |
| 2022 | €3.90 | +6.3% | Verified fact |
| 2023 | €4.60 | +17.9% | Verified fact |
| 2024 | €4.79 | +4.1% | Verified fact |
| 2025 | €5.16 | +7.7% | Verified fact; €2.59 interim plus €2.57 balance |

**Estimate.** The 2021–2025 dividend CAGR is 8.89% over four intervals. There were four increases, no holds, cuts or suspensions in that five-year window. The longer record is not unbroken: the dividend for 2019 was set to zero following the ECB's pandemic distribution recommendation.

**Verified fact.** BNP introduced semiannual payment from the 2025 financial year. The €2.59 interim was paid 30 September 2025; the €2.57 balance went ex-dividend 18 May 2026, record date 19 May and payment 20 May. The 2026 interim amount and exact dates were not declared by the cutoff; management describes payment around 30 September.

**Analytical judgment.** Waiting for an ex-dividend date is not a free gain: the share price theoretically adjusts by the cash distribution. Calendar timing must not justify buying a weak or overallocated position.

## 6. Distribution coverage and safety

| Measure | Latest | Assessment |
|---|---:|---|
| 2025 EPS | €10.29 | Verified fact |
| 2025 dividend/share | €5.16 | Verified fact |
| Cash payout | 50.0% official | Verified fact |
| EPS coverage | 1.99× | Estimate |
| 1Q26 net income, group share | €3.217bn, +9.0% YoY | Verified fact |
| 1Q26 cost of risk | €922m / 39 bps | Verified fact; near management ceiling |
| 1Q26 RoTE | 12.8% | Verified fact |

**Verified cross-check.** The financial tool reconciled 1Q26 revenue at €14.056bn (BNP) versus €14.060bn (Reuters), a 0.01% deviation from the median; net income €3.217bn versus €3.220bn, a 0.05% deviation. BNP's €5.16 2025 dividend differs from StockAnalysis's €5.14 annualized figure by 0.19% from the median, within tolerance; issuer/AGM cash payments control.

**Analytical judgment.** Coverage is strong today. The leading warning is not the payout ratio but cost of risk: at 39 bps, it already sits at the edge of management's below-40-bps 2026 guidance. A worsening credit cycle can reduce earnings and capital simultaneously.

## 7. Balance sheet and refinancing

**Verified fact.** At 31 March 2026, CET1 was 12.8%, 238 bps above the 10.42% requirement. The leverage ratio was 4.4%, the liquidity coverage ratio 125%, HQLA €359bn and immediately available liquidity reserve €464bn.

**Verified fact.** BNP reported €18bn CET1 distance and €16bn minimum overall distance to Maximum Distributable Amount restrictions. Total capital was 17.3% versus a 14.60% requirement. These are buffers, not cash available to shareholders.

**Verified fact.** The 2026 regulatory issuance plan was €14bn; about 60% was completed by 1 May 2026. Wholesale medium/long-term funding outstanding was €264bn, with economic maturities spread across years. BNP showed €13bn of senior non-preferred maturities in 2026, €11bn in 2027 and €11bn in 2028.

**Analytical judgment.** Refinancing is manageable in the base case. A market-access freeze would still be material because BNP is a leveraged G-SIB; liquidity reserves and loss-absorbing debt reduce, but do not eliminate, that tail risk.

## 8. Income growth

**Verified fact.** Dividend/share rose from €3.67 in 2021 to €5.16 in 2025 while 2025 EPS increased to €10.29. 1Q26 revenue growth of 8.5% and net-income growth of 9.0% support near-term distributable-earnings momentum.

**Analytical judgment.** A normalized 3–6% dividend growth range is more prudent than extrapolating the 8.89% historical CAGR. Capital requirements, credit losses, share count, legal costs and the split between dividends and buybacks will determine actual growth.

**Verified fact.** A €219m 1Q26 provision for UK motor-finance legal risk reduced group net income by €98m after tax and minorities. This illustrates why accounting/legal charges can interrupt a smooth dividend-growth path even when underlying operations improve.

## 9. Valuation and margin of safety

| Metric at €102.32 | Result | Status |
|---|---:|---|
| PE on 2025 EPS | 9.94× | Exact estimate |
| Earnings yield | 10.06% | Exact estimate |
| Price / 2025 net book value | 0.98× | Exact estimate |
| Trailing dividend yield | 5.04% | Exact estimate |
| DEGIRO P/E field | 7.64× | Supplied fact; not used because its earnings denominator is undocumented |

**Estimate.** A simple year-end indicated-yield proxy using issuer year-end prices and the corresponding dividends for 2021–2025 averages 7.04%. It is not a time-weighted historical yield. Today's 5.04% is below that proxy, showing that the stock has rerated rather than offering exceptional income value.

**Analytical judgment.** Appropriate bank valuation anchors are PE, price/book, sustainable RoTE and capital—not FCF yield. A reasonable current intrinsic range is €90–€115. The supplied price is 12.0% above the lower bound and offers only 12.4% upside to the upper bound before dividends: adequate for holding, thin for adding.

**Estimate.** At €90, the trailing yield would be 5.73%; at €85, 6.07%. Those levels better compensate for cyclicality and the unresolved litigation tail.

## 10. Tax and currency

**Verified fact.** The share and distributions are denominated in EUR, matching the portfolio's reference currency. BNP's underlying earnings remain exposed to GBP, USD and other currencies through international operations.

**Verified fact.** France's official 2026 guidance states that the default PFU for dividends comprises 12.8% income tax plus 18.6% social levies, or 31.4% in total. A progressive-scale election is global across relevant investment income and may permit a 40% dividend allowance; its benefit depends on the taxpayer's full situation.

| Holding calculation | Gross | Simplified PFU scenario |
|---|---:|---:|
| 3 shares × €5.16 | €15.48/year | €10.62/year after 31.4% |
| Per semiannual payment | Not calculable prospectively | Not calculable prospectively |

**Assumption.** The €10.62 scenario assumes a French-resident individual, ordinary CTO, default PFU, no exemption and full application of the 2026 rates.

**Data gap.** DEGIRO's actual French advance withholding, social-levy collection and declaration timing were not confirmed. The issuer's own tax page still displayed the older 17.2% social rate at the cutoff, while Service Public had been updated to 18.6%. Therefore €10.62 is a tax scenario, not confirmed cash income; professional tax advice may be needed.

## 11. Portfolio fit

| Item | Result | Status |
|---|---:|---|
| Quantity | 3 shares | Supplied fact |
| Position value | €306.96 | Supplied fact |
| Cost basis | €64.55/share | Supplied fact |
| Portfolio weight | 3.43% | Supplied/verified portfolio report |
| Total financial exposure | 21.38% | Verified portfolio report |
| Gross yield on cost | 7.99% | Exact estimate; retrospective only |
| Annual gross income at last DPS | €15.48 | Exact estimate |
| Contribution to portfolio value as gross income | 0.173% / 17.3 bps | Exact estimate |

**Analytical judgment.** Company quality and allocation fit diverge: BNP itself merits conviction-income status, but the portfolio already holds Crédit Agricole, Bank of America and T. Rowe Price. Adding would deepen correlated exposure to credit, rates and financial-market stress. The current 3.43% weight is reasonable; total finance concentration blocks reinforcement.

**Data gap.** Contribution to total portfolio dividend income is not calculable because verified forward distributions for every holding were not provided. No proposed trade quantity was supplied, so after-trade weight and income are not calculable.

### Expected gross income by month

| Month | Confirmed/expected BNP gross income for current 3 shares |
|---|---:|
| May 2026 | €7.71 only if the shares were held through the record date; the July snapshot does not prove that |
| Around September 2026 | Unknown; 2026 interim not declared at cutoff |
| Other months | €0 under the stated semiannual policy |

## 12. Scenarios: base, adverse, severe

These are stress tests, not forecasts. Values use exact arithmetic and exclude any separate value assigned to buybacks.

| Case | Operating and distributable-earnings assumptions | Coverage/capital | Dividend outcome | Valuation implication |
|---|---|---|---|---|
| Base | **Assumption:** 2026 EPS €10.90; cost of risk ≤40–45 bps; AXA IM integration broadly on plan | **Estimate:** 50% cash payout; CET1 12.8–13.0%; coverage 2.0× | **Estimate:** €5.45/share, +5.6% | **Estimate:** 9–10× EPS = €98.10–€109.00 |
| Adverse | **Assumption:** EPS 25% below 2025 at €7.72; cost of risk ~60 bps; weaker CIB/retail fees | **Estimate:** CET1 11.8–12.2%; refinancing cost rises; 50% payout | **Estimate:** €3.86/share, a 25% cut | **Estimate:** 7–8× = €54.02–€61.74 |
| Severe | **Assumption:** EPS 50% below 2025 at €5.15; cost of risk >100 bps; major legal/credit loss and market-access stress | **Estimate:** CET1 approaches regulatory buffers; payout retained at 40% or regulator limits distributions | **Estimate:** €2.06/share, a 60% cut | **Estimate:** 5–7× = €25.72–€36.02 |

**Analytical judgment.** The base case supports the dividend but offers modest price upside. The adverse and severe cases show why a 5% yield cannot be treated as bond-like: price loss and dividend cuts can occur together.

## 13. Dividend-cut risks

| Risk | Transmission to dividend | Current signal |
|---|---|---|
| European credit recession | Higher provisions reduce earnings and CET1 | Cost of risk already 39 bps; watch closely |
| Capital/regulatory intervention | ECB can restrict distributions; MDA buffer can shrink | Current headroom strong |
| Sudan litigation | Settlement/judgment could consume earnings/capital and damage confidence | Appeal pending; tail amount unresolved |
| UK motor finance | Further provisions reduce distributable earnings | €219m provision in 1Q26 |
| CIB/market volatility | Trading and advisory earnings can fall | 1Q26 CIB revenue -0.8% reported, +3.1% constant scope/FX |
| Funding/liquidity shock | Higher spreads and deposit competition compress earnings | Current LCR 125%; issuance progressing |
| Political taxation | Bank levies or windfall taxes reduce capital generation | Persistent European sector risk |

**Verified fact.** A U.S. jury awarded about $21m to three Sudanese plaintiffs in October 2025. BNP filed its opening appeal brief on 22 May 2026; the potential broader class effect remains contested and unquantified. **Analytical judgment:** this is the main low-probability/high-impact integrity and dividend tail risk.

## 14. Purchase or reinforcement conditions

**Analytical judgment.** Do not add now. Reconsider only when all of the following hold:

- price at or below €90, preferably below €85 for a strong margin of safety;
- CET1 at least 12.5% and clear progress toward 13% in 2027;
- cost of risk no worse than 40–45 bps and no sharp impaired-loan acceleration;
- confirmed interim dividend consistent with at least a 50% cash payout;
- no material adverse Sudan judgment/settlement or unreserved legal charge;
- portfolio finance exposure about 20% or less after the trade.

**Analytical judgment.** Do not buy merely before an ex-dividend date. The price adjustment and 31.4% PFU baseline eliminate any mechanical income advantage.

## 15. Reduction or sale conditions

**Analytical judgment.** Study reduction if any one fundamental condition becomes persistent: CET1 below 11.5%; cost of risk above 60 bps for two periods; capital distribution suspended for bank-specific reasons; an inadequately reserved legal loss that threatens the 2027 capital target; or a structural fall in RoTE below the cost of equity.

**Analytical judgment.** Study valuation-led trimming above €125 unless sustainable RoTE rises above roughly 11–12% and dividend growth justifies the rerating. Also trim/rebalance if BNP exceeds 5% or finance exposure rises materially above the current 21.38%.

**Analytical judgment.** Yield on cost of 7.99% is not a hold reason. The decision must use current value, forward income and alternative uses of capital.

## 16. Monitoring table

| Indicator | Latest / next event | Green | Warning | Action trigger |
|---|---|---|---|---|
| CET1 | 12.8% at 2026-03-31 | ≥12.5% | 11.5–12.5% | <11.5% |
| SREP CET1 requirement | 10.42% | Buffer >200 bps | 100–200 bps | <100 bps |
| Cost of risk | 39 bps 1Q26 | ≤40 bps | 40–60 bps | >60 bps twice |
| Net income | €3.217bn 1Q26 | Positive YoY growth | Flat/down modestly | >25% normalized decline |
| Cash payout | ≥50% policy | ≥50% with stable CET1 | <50% explained | Cut/suspension bank-specific |
| 2026 interim dividend | Not declared | Consistent with 50% H1 EPS | Material shortfall | Cancellation |
| LCR | 125% | ≥120% | 110–120% | Near 100% |
| Sudan litigation | Appeal pending | Reversal/contained settlement | Uncertain class expansion | Capital-threatening judgment |
| Portfolio finance weight | 21.38% | ≤20% | 20–25% | >25% |
| Next results | 2Q26 on 2026-07-23 | — | — | Refresh report after release |

## 17. One-sentence conclusion

**`HOLD – DO NOT ADD`: BNP Paribas currently offers covered, growing conviction income, but a 5.04% yield at fair value does not compensate enough to increase an already finance-heavy portfolio before 2Q26 results and clearer litigation/tax-withholding evidence.**

## 18. Sources and data quality

Evidence quality is **A-**. Decision-critical 1Q26 revenue and net income were cross-checked against Reuters within 0.1%; dividend/share was checked against StockAnalysis within 1%, with the issuer's approved cash amounts controlling. Portfolio facts come from the supplied file and its same-day audited portfolio review. The material gaps are 2Q26 (scheduled after the cutoff), the undeclared 2026 interim dividend, the unquantified Sudan tail and DEGIRO's exact withholding workflow.

| Source title | Issuer/publisher | Publication date | Accessed | Reporting period | Type | URL |
|---|---|---:|---:|---|---|---|
| First Quarter 2026 Results | BNP Paribas | 2026-04-30 | 2026-07-15 | 1Q26 | Primary | https://invest.bnpparibas/document/1q26-pr |
| Debt Investors Presentation — May 2026 | BNP Paribas | 2026-05-13 | 2026-07-15 | 2026-03-31 / May 2026 | Primary | https://invest.bnpparibas/document/debt-investors-presentation-roadshow-13-15-may-2026 |
| 2025 Universal Registration Document and Annual Financial Report | BNP Paribas | 2026-03-13 | 2026-07-15 | FY2025 | Primary | https://invest.bnpparibas/en/document/universal-registration-document-annual-financial-report-2025-pdf |
| 2026 AGM Convening Notice | BNP Paribas | 2026-03-13 | 2026-07-15 | FY2025 dividend | Primary | https://invest.bnpparibas/en/document/agm-2026-convening-notice |
| BNP Paribas share — dividend history | BNP Paribas | Continuously updated | 2026-07-15 | 1998–2025 | Primary | https://invest.bnpparibas/en/bnp-paribas-share |
| Sudan Litigation: Statement from BNP Paribas | BNP Paribas | 2026-06-01 | 2026-07-15 | Appeal status | Primary, interested party | https://invest.bnpparibas/en/document/sudan-litigation-statement-from-bnp-paribas |
| BNP Paribas reports 9% rise in Q1 profit | Reuters, republished by LSE.co.uk | 2026-04-30 | 2026-07-15 | 1Q26 | Secondary, independent | https://www.lse.co.uk/news/bnp-paribas-reports-9-rise-in-q1-profit-investment-bank-stutters-b0k26rdtztkf2of.html |
| US jury issues $20M verdict against BNP Paribas | Associated Press | 2025-10-18 | 2026-07-15 | Sudan trial verdict | Secondary, independent | https://apnews.com/article/7bacbbb049bc79e1dfa805a02e06bd3c |
| BNP Paribas dividend history | StockAnalysis | 2026-06 | 2026-07-15 | 2025/2026 annualized | Secondary, independent | https://stockanalysis.com/quote/epa/BNP/dividend/ |
| Impôt sur le revenu — revenus d'épargne et de placement — revenus 2026 | Service Public / DILA | 2026-04-15 | 2026-07-15 | Tax year 2026 | Primary official guidance | https://www.service-public.gouv.fr/particuliers/vosdroits/F34913/1_7?lang=fr |
| BNP PARIBAS, FR0000131104 | Euronext | Continuously updated | 2026-07-15 | Market/corporate actions | Primary exchange | https://live.euronext.com/fr/product/equities/FR0000131104-MTAH |
| Revue du portefeuille — CTO DEGIRO | AI Berkshire / supplied data | 2026-07-15 | 2026-07-15 | Portfolio snapshot 2026-07-15 | Internal primary input | reports/portfolio-degiro-20260715.md |

### Calculation log

`tools/financial_rigor.py` verified PE 9.94×, earnings yield 10.06%, P/B 0.98×, ROE 9.87% and yield 5.04%. Exact calculations covered gross/net income, yield on cost, portfolio contribution, dividend CAGR, historical-yield proxy, entry yields and all three scenarios. Cross-validation found no decision-critical discrepancy above 1%; StockAnalysis's €5.14 is an annualized data-vendor figure, while BNP's €5.16 equals the two approved cash payments and is retained.